Biotechnology

Japan has one of the most developed biotechnology sectors in the world, as evidenced by the high number of patents filed. Although the number of bio venture start-ups peaked in 2006, several foreign firms are now trying to enter the market. Moreover, the government is supporting the sector’s development and has passed several laws to assist it; it is being viewed as a national strategy. Find out more about Japan's biotechnology sector below.

About Biotechnology

With an ever-increasing number of bio-ventures and the establishment of a new ecosystem in the Japanese biotech field, this sector offers many opportunities for European SME companies.

Bioinformatics

With Asia’s largest bioinformatics database located in Japan, the sector will be of an increasing importance, especially with its application to the medical and pharmaceutical industries.

Biopharmaceuticals

Japan is the third largest pharmaceutical market in the world, and the biologically active substances (biopharmaceuticals) are considered to be the driving force behind innovation in this industry.

Biotechnology in Agriculture

— Latest update: December 2023 —

Subscribe to
our newsletters

The EU-Japan Centre currently produces 5 newsletters :

EU-Japan NEWS - our flagship newsletter covering the Centre's support services, information about EU (or Member States) - Japan cooperation
Japanese Industry and Policy News
“About Japan” e-News (Only available for EU companies / EU organisations)
Japan Tax and Public Procurement Weekly Tender Digest (Only available for EU companies / EU organisations)
Tech Transfer Helpdesk Newsletter

Brussels

Tokyo

1 EUR = 156,548 JPY

EU-Japan Centre for Industrial Cooperation

Joint venture established in 1987 by the European Commission (DG GROW) and the Japanese Government (METI) for promoting all forms of industrial, trade and investment cooperation between the EU and Japan.

The EU-Japan Centre’s activities are subject to the allocation of a Grant Agreement by the European Commission for 2024-2026